Benchmark downgraded AbCellera to Hold from Buy.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ABCL:
- AbCellera participates in a conference call with Truist
- AbCellera presents new data on two T-cell engager programs
- AbCellera reports Q3 EPS (8c), consensus (13c)
- Prelude, AbCellera team on precision antibody drug conjugates in oncology
- AbCellera assumed with an Overweight at Piper Sandler
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue